As upstream process development increasingly relies on high-throughput bioreactor platforms, the ability to generate dense, consistent and decision-grade process data has become a critical limiting factor. While parallel bioreactors accelerate experimentation, insufficient analytical resolution can slow learning cycles and weaken confidence in optimization outcomes.
In this webinar, the featured speakers will present insights from a recent CHO fed-batch optimization study that used parallel bioreactors and a statistically rigorous design-of-experiments (DoE) framework to evaluate seeding density and feeding strategy. High frequency, multi-analyte process monitoring, enabled through an integrated analytical workflow, supported robust process mapping, metabolic interpretation and confident identification of optimal operating ranges.
Attendees will gain perspective on how analytics designed to keep pace with high-throughput experimentation strengthen DoE execution, reduce uncertainty in upstream decision-making and accelerate translation from early-stage development to scalable, transfer-ready processes.
Register for this webinar to learn how process optimization in CHO fed-batch development can be accelerated through high-throughput analytics and stronger process data.
Speakers
Shweta Nair, Director of Bioprocessing, Nova Biomedical
Shweta Nair is the Director of Bioprocessing at Nova Biomedical, with over a decade of experience in the biopharmaceutical and life sciences industries. Since joining Nova in 2019, she has led the development and launch of innovative analytical technologies that improve accuracy, reliability and data integrity across the bioprocessing workflow.
Shweta drives product and business strategy through strong customer partnerships and a deep understanding of evolving industry needs. A collaborative leader, she is committed to building high-performing, cross-functional teams and translating customer insights into impactful solutions. Prior to Nova Biomedical, she worked in global roles at MilliporeSigma, managing laboratory equipment for biopharma and research applications.
Achinta Bordoloi, Research Scientist, University of Oklahoma
More information coming soon.
Who Should Attend?
This webinar is of value to:
- Process Development Scientists and Engineers working in upstream biologics development
- Bioprocessing teams in biotech companies and CDMOs seeking to accelerate CHO fed batch optimization
- Scientists responsible for DoE execution, process characterization or scale-down modelling
- MSAT and CMC professionals focused on improving process understanding and transfer readiness
- R&D and Automation leaders aiming to shorten development timelines through better process data
What You Will Learn
Attendees will gain insights into:
- How high frequency, integrated analytics enhance process mapping in CHO fed batch development
- The role of comprehensive daily monitoring in strengthening DoE models and optimization outcomes
- Practical considerations for interpreting metabolic and growth trends to guide feeding and seeding strategies
- How richer process data can reduce uncertainty, accelerate learning cycles and support scalable process decisions
Xtalks Partner
Nova Bio
Advanced Instruments and Nova Biomedical are now doing business under the same brand, bringing together decades of expertise in analytical instrumentation, R&D, and global customer support. The Solentim® ecosystem is now part of Nova Biomedical’s portfolio, providing best-in-class imaging and single-cell deposition technologies for cell line development workflows and assurance of clonality for regulatory bodies.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account